BCL2L11を家族全体のエクソーム配列を用いた非髄膜性甲状腺がんへの遺伝的傾向の候補遺伝子として特定
Duygu Abbasoglu1,2, Mathis Lepage1,2, Nicolas Sonnier1,2
1Département d'Oncogénétique, Centre Jean Perrin, Clermont-Ferrand, France.
Clinical genetics
|September 4, 2025
まとめ
遺伝的要因は家族性非髄性甲状腺がん (FNMTC) に大きく寄与する. 研究者はBCL2L11を含む3つの候補遺伝子を特定し,これは遺伝性甲状腺癌の役割を示唆する腫瘍抑制活性を示しています.
科学分野:
- 腫瘍学
- 遺伝学
- 分子生物学
背景:
- 家族性非骨髄性甲状腺がん (FNMTC) は,甲状腺がんの3%から9%を占め,攻撃的な疾患の特徴と関連しています.
- 単一の高浸透性遺伝子は特定されていませんが,遺伝子はFNMTCの傾向に重要な役割を果たしています.
- FNMTCは早期診断,多焦点性,転移および再発リスクの増加と関連しています.
研究 の 目的:
- 家族性非骨髄性甲状腺がん (FNMTC) の潜在的遺伝因子を特定する.
- 甲状腺がん発生における候補腫瘍抑制遺伝子の役割を調査する.
- 甲状腺がんの細胞モデルで 候補遺伝子を機能的に検証する
主な方法:
- 全エクソームシーケンシング (WES) を用いて,FNMTCを持つ5つの家族を分析した.
- チリコとインハウスのサンプル分析で,腫瘍と健康な甲状腺組織の遺伝子発現レベルが評価されました.
- 候補遺伝子が増殖とアポトーシスに与える影響を評価するために,甲状腺がん細胞で機能分析を行った.
主要な成果:
- 3つの候補遺伝子 (TELO2,UACA,BCL2L11) が研究されたファミリーで特定されました.
- すべての候補遺伝子は甲状腺で発現し,腫瘍組織では発現が少ない.
- BCL2L11は,機能分析で増殖とアポトーシスに対する腫瘍抑制効果を示した.
- FOXO3A経路を通じて2つの遺伝子が甲状腺がん発生に関与しています.
結論:
- 特定された遺伝子,特にBCL2L11は,甲状腺がんへの遺伝的傾向の潜在的な候補である.
- FNMTCにおけるその役割と診断上の有用性を確認するために,症例対照研究を含むさらなる研究が必要である.
- 甲状腺がんにおけるこれらの遺伝子の結合効果と正確なメカニズムについては,さらなる調査が必要である.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
The Retinoblastoma Gene
3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K


